| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-10 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.27 | 2e-08 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |